Antigenotoxic effect of lipoic acid against mitomycin-C in human lymphocyte cultures

Cytotechnology

Volumn 65, Issue 4, 2013, Pages 553-565

  Unal, Fatma ^a   Taner, Gokce ^a   Yuzbasioglu, Deniz ^a   Yilmaz, Serkan ^b  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Antigenotoxic effect; Chromosomal aberrations; Lipoic acid; Micronucleus; Mitomycin C (MMC); Sister chromatid exchanges

Indexed keywords

MITOMYCIN; SOLVENT; THIOCTIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; FEMALE; GENOTOXICITY; HUMAN; HUMAN EXPERIMENT; LYMPHOCYTE; LYMPHOCYTE CULTURE; MALE; NORMAL HUMAN; SISTER CHROMATID EXCHANGE;

EID: 84881127172     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-012-9504-8     Document Type: Article

References (107)

1. Abraham SK, Eckhardt A, Oli RG, Stoper H (2012) Analysis of in vitro chemoprevention of genotoxic damage by phytochemicals, as single agents or as combinations. Mutat Res 744:117-124
2. Ahmad N, Feyes DK, Nieminen AL, Agarwal R, Mukhtar H (1997) Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89:1881-1886
3. Akiba S, Matsugo S, Packer L, Konishi T (1998) Assay of protein-bound lipoic acid in tissues by a new enzymatic method. Anal Biochem 258:299-304
4. Albertini RJ, Anderson D, Douglas GR, Hagmar L, Heminiki F, Merelo F, Natrajan AT, Norppa H, Shuker DEG, Tice R, Walters MD, Aitio A (2000) IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat Res 463:111-172
5. Ananthi R, Chandra N, Santhiya ST, Ramesh A (2010) Genotoxic and antigenotoxic effects of Hemidesmus indicus R. Br. root extract in cultured lymphocytes. J Ethnopharmacol 127:558-560
6. Aydemir N, Çelikler S, Bilaloǧlu R (2005) In vitro genotoxic effects of the anti-cancer drug gemcitabine in human lymphocytes. Mutat Res 582:35-41
7. Azam S, Hadi N, Khan NU, Hadi SM (2004) Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol In Vitro 18:555-561
8. Aziz K, Nowsheen S, Pantelias G, Iliakis G, Gorgoulis VG, Georgakilas AG (2012) Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy. Pharmacol Therapeut 133:334-350
9. Begum N, Prasad NR, Kanimozhi G, Hasan AQ (2012) Apigenin ameliorates gamma radiation-induced cytogenetic alterations in cultured human blood lymphocytes. Mutat Res 747:71-76
10. Bengmark S, Mesa MD, Gil A (2009) Plant drived health: the effects of turmeric and curcuminoids. Nutr Hosp 24:273-281
11. Bhouri W, Boubaker J, Kilani S, Ghedira K, Chekir-Ghedira L (2012) Flavonoids from Rhamnus alaternus L. (Rhamnaceae): kaempferol 3-O-β-isorhamninoside and rhamnocitrin 3-O-β-isorhamninoside protect against DNA damage in human lymphoblastoid cell and enhance antioxidant activity. S Afr J Bot 80:57-62
12. Biewenga GP, Haenen GRMM, Bast A (1997) The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 29:315-331
13. Bilska A, Wlodek L (2005) Lipoic acid-the drug of the future? Pharmacol Rep 57:570-577
14. Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F (2010) Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with alpha-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism. Life Sci 86:844-853
15. Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, Gundy S, Lazutka J, Cebulska-Wasilewska A, Puskailerova D, Znaor A, Kelecsenyi Z, Kurtinaitis J, Rachtan J, Forni A, Vermeulen R, Bonassi S (2007) Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am J Epidemiol 165:36-43
16. Bonassi S, Abbondandolo A, Camurri L, Dal Prá L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, Sbrana I, Vecchio D, Puntoni R (1995) Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135
17. Bonassi S, Ugolini D, Kirsch-Volders M, Stromberg U, Vermeulen R, Tucker JD (2005) Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ Mol Mutagen 45:258-270
18. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625-631
19. Bonassi S, Norppa H, Ceppi M, Strömberg U, Vermeulen R, Znaor A, Cebulska-Wasilewska A, Fabianova E, Fusic A, Gundy S, Hansteen IL, Knudsen LE, Lazutka J, Rossner P, Sram RJ, Boffetta P (2008) Chromosomal aberration frequency in lymphocytes predicts risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 29:1178-1183
20. Bonorden WR, Pariza MW (1994) Antioxidant nutrients and protection from free radicals. Nutritional Toxicology, Raveb, pp 19-48
21. Bounias M, Kladny J, Kruk I, Michalska T, Lichszteld K (1997) Effect of catechols on free radical formation by chemotherapeutic agents adriamycin, farmorubicin, and mitomycin. Cancer Detect Prev 21:553-562
22. Burgaz S, Coskun E, Demircigil GC, Kocabas NA, Cetindag F, Sunter O, Edinsel H (2011) Micronucleus frequencies in lymphocytes and buccal epithelial cells from patients having head and neck cancer and their first-degree relatives. Mutagenesis 26:351-356
23. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH (1998) Alpha-lipoic acid in liver metabolism and disease. Free Radical Bio Med 24:1023-1039
24. Çakatay U (2006) Pro-oxidant actions of α-lipoic acid and dihydrolipoic acid. Med Hypotheses 66:110-117
25. Cimons M (1988) Cancer rates decline as cancer funding increases. Nat Med 4:544-548
26. Clement M, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signalling dependant apoptosis in human tumor cells. Blood 92:996-1002
27. Cremer DR, Rabeler R, Roberts A, Lynch B (2006) Safety evaluation of α-lipoic acid (ALA). Regul Toxicol Pharm 46:29-41
28. Crooke ST, Bradner WT (1976) Mitomycin C: a review. Cancer Treat Rev 3:121-139
29. D'Incalci M, Steward WP, Gescher AJ (2005) Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 6:899-904
30. Davis GDJ, Masilamoni JG, Arul V, Kumar MSM, Baraneedharan U, Paul SFD, Sakthivelu IV, Jesudason EP, Jayakumar R (2009) Radioprotective effect of DL-α-lipoic acid on mice skinfibroblasts. Cell Biol Toxicol 25:331-340
31. De Flora S, Ferguson LR (2005) Owerview of mechanisms of cancer chemoproventive agents. Mutat Res 591:8-15
32. De Flora S, Izzotti A, Randerath K, Randerarth E, Bartsch H, Nair J, Balansky R, van Schooten F, Degan P, Fronza G, Walsh D, Lewtas J (1996) DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat Res 366:197-238
33. De Flora S, Izzotti A, D'Agostini F, Balansky R, Noonan D, Albini A (2001) Multiple points of intervention in the prevention of cancer and other mutation releated diseases. Mutat Res 480(481):9-22
34. De Flora S, Quaglia A, Bennicelli C, Vercelli M (2005) The epidemiological revolution of the 20th century. FASEB J 19:892-897
35. Deans AJ, West SC (2011) DNA interstrand crosslink repair and cancer. Nat Rev Cancer 11:467-489
36. Del Rio D, Costa LG, Lean ME, Crozier A (2010) Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis 20:1-6
37. dos Santos GC, Mendonça LM, Antonucci GA, dos Santos AC, Antunes LMGA, Bianchi MLP (2012) Protective effect of bixin on cisplatin-induced genotoxicity in PC12 cells. Food Chem Toxicol 50:335-340
38. Drisko JA, Chapman J, Hunter VJ (2003) The use of antioxidant therapies during chemotherapy. Gynecol Oncol 88:434-439
39. Duthie SJ (2011) Epigenetic modifications and human pathologies: cancer and CVD. P Nutr Soc 70:4756. doi: 10.1017/S0029665110003952
40. El-Zein R, Vral A, Etzel CJ (2011) Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 26:101-106
41. Fenech M (2006) Cytokinesis-block micronucleus assay evolves into a cytome assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 600:58-66
42. Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084-1104
43. Fenech M, Morley A (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36
44. Fu J, Liang X, Chen Y, Tang L, Zhang QH, Dong Q (2008) Oxidative stress as a component of chromium-induced cytotoxicity in rat calvarial osteoblasts. Cell Biol Toxicol 24(3):201-212
45. Garcia AL, Filippi S, Mosesso P, Calavani M, Nicolai R, Mosconi L, Palitti F (2006) The protective effect of L-carnitine in peripheral blood human lymphocytes exposed to oxidative agents. Mutagenesis 21:21-27
46. Gebhart E (1992) Anticlastogenicity in cultured mammalian cells. Mutat Res 267:211-220
47. Gentile JM, Rahimi S, Zwiesler J, Gentile GJ, Ferguson LR (1998) Effect of selected antimutagens on the genotoxicity of antitumor agents. Mutat Res 402:289-298
48. Goraca A, Aslanowicz-Antkowiak K (2009) Prophylaxis with alpha-lipoic acid against lipopolisaccharide-induced brain injury in rats. Arch Immunol Ther Exp (Warsz) 57:141-146
49. Goraca A, Piechota A, Huk-Kolega H (2009) Effect of alphalipoic acid on LPS-induced oxidative stress in the heart. J Physiol Pharmacol 60:61-68
50. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B (2011) Lipoic acid-biological activity and therapeutic potential. Pharmacol Rep 63:849-858
51. Grisolia CK (2002) A comparison between mouse and fish micronucleus test using cyclophosphamide, mitomycin C and various pesticides. Mutat Res 518:145-150
52. Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudson JE, Norppa H, Reuterwall C (1998) Chromosomal aberration in human lymphocytes predict human cancer: a report from the Eoropean study group on cytogenetic biomarkers and health (ESCH). Cancer Res 58:4117-4121
53. Han D, Handelman G, Marcocci L, Sen CK, Roy S, Kobuchi H, Tritschler HJ, Flohe L, Packer L (1997) Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. BioFactors 6:321-338
54. Hernandez-Ceruelos A, Madrigal-Bujaidar E, Cruz C (2002) Inhibitory effect of chamomile essential oil on the sister chromatid exchanges induced by daunorubicin and methylmethanesulfonate in mouse bone marrow. Toxicol Lett 135:103-110
55. Ho YS, Lai CS, Liu HI, Ho SY, Tai C, Pan MH, Wang YJ (2007) Dihydrolipoic acid inhibits skin tumor promotion through anti-inflammation and anti-oxidation. Biochem Pharmacol 73:1786-1795
56. Iarmarcovai G, Ceppi M, Botta A, Orsière T, Bonassi S (2008) Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. Mutat Res 659:274-283
57. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidem Biomar 19:1893-1907
58. Krishna G, Nath J, Ong T (1986) Inhibition of cyclophosphamide and mitomycin C induced sister chromatid exchanges in mice by vitamin C. Cancer Res 46:2670-2676
59. Lee HS, Na MH (2010) Kim WK (2010) α-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer line. Nutr Res 30:403-409
60. Lee KW, Bode AM, Dong Z (2011) Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 11:211-218
61. Levi F, Lucchini F, Negri E, La Vecchia C (2002) Cancer mortality in the European Union. Int J Cancer 98:636-637
62. Lodge L, Handelman GJ, Konishi T, Matsugo S, Mathur VV, Packer L (1997) Natural sources of lipoic acid: determination of lipoyllysine released from protease digested tissues by high performance liquid chromatography incorporating electrochemical detection. J Appl Nutr 49:3-11
63. Lonkar P, Dedon PC (2011) Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 128:1999-2009
64. Lu BB, Kang HL (2012) Lipoic acid prevents steroid-induced osteonecrosis in rabbits. Rheumatol Int 32:1679-1683
65. Mamur S, , Yüzbasioǧlu D, Ünal F, Aksoy H (2012) Genotoxicity of food preservative sodium sorbate in human lymphocytes in vitro. Cytotechnology 64:553-562. doi: 10.1007/s10616-012-9434-5
66. Maurya DK, Devasagayam TPA (2010) Antioxidant and prooxidant nature of hydrocynnamic acid derivatives ferulic acid and caffeic acids. Food Chem Toxicol 48:3369-3373
67. McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C (2010) Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med 52:1028-1034
68. Moini H, Packer L, Saris NE (2002) Antioxidant and prooxidant activities of α-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182:84-90
69. Montoro A, Soriano JM, Barquinero JF, Almonacid M, Montoro A, Verdu G, Sahuquillo V, Villaescusa JI, Sebastia N (2012) Assessment in vitro of cytogenetic and genotoxic effects of propolis on human lymphocytes. Food Chem Toxicol 50:216-221
70. Nichols TW (1997) α-Lipoic acid: biological effects and clinical implications. Altern Med Rev 2:177-183
71. Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Boffetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Štrám RJ, Knudsen LE, Barale R, Fucic A (2006) Chromosomal aberrations and SCE as biomarkers of cancer risk. Mutat Res 600:37-45
72. Novogrodsky A, Ravid A, Rubin AL, Stenzel KH (1982) Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci USA 79:1171-1174
73. Novonty L, Rauko P, Cojocel C (2008) α-Lipoic acid-the potential for use in cancer therapy. Neoplasma 55:81-86
74. Obe G, Pfeiffer P, Savage JRK, Johannes C, Goedecke W, Jeppesen P, Natarajan AT, Martinez-Lopez W, Folle GA, Drets ME (2002) Chromosomal aberrations: formation, identification and distribution. Mutat Res 504:17-36
75. Pack RA, Hardy K, Madigan MC, Hunt NH (2001) Differential effects of the antioxidant α-lipoic acid on the proliferation of mitogen-stimulated peripheral blood lymphocytes and leukaemic T cells. Mol Immunol 38:733-745
76. Packer L, Witt EH, Tritschler HJ (1995) Alpha-lipoic acid as a biological antioxidant. Free Radical Bio Med 19:227-250
77. Packer L, Tritschler HJ, Wessel K (1997) Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radical Biol Med 22:359-378
78. Palus J, Rydzynski K, Dziubaltowska E, Wyszynska K, Natarajan AT, Nilsson R (2003) Genotoxic effects of occupational exposure to lead and cadmium. Mutat Res 540:19-28
79. Pierce RH, Campbell JS, Stephenson AB, Franklin CC, Chaisson M, Poot M, Kavanagh TJ, Rabinovitch PS, Fausto N (2000) Disruption of redox homeostasis in tumor hepatocyte cell line. Am J Pathol 157:221-236
80. Pierce DR, Cook CC, Hinson JA, Light KE (2006) Are oxidative mechanisms primary in ethanol induced Purkinje neuron death of the neonatal rat? Neurosci Lett 400:130-134
81. Prahalathan C, Selvakumar E, Varalakshmi P, Kumarasamy P, Saravanan R (2006) Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Toxicology 222:225-232
82. Pronko PS, Khomich TI, Bardina LR, Satanovskaya VI, Borodich OA (2006) Effect of amino acid derivatives and lipoic acid on lipid peroxidation and antioxidant system indices in the rat brain during alcohol withdrawal. Eur Neuropsychopharmacol 16
83. Rossner P, Boffetta P, Ceppi M, Bonassi S, Smerhovsky Z, Landa K, Juzova D, Srám RJ (2005) Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect 113:517-520
84. Scarpato R, Paganucci L, Bertoli A, Fiore L, Pistelli L, Federico G (2008) Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes. Phytother Res 22:1650-1654
85. Scott BC, Auroma OI, Evans PJ, O'Neill C, Van der Vliet A, Cross CE, Tritschler H, Halliwell B (1994) Lipoic and dihydrolipoic acids as antioxidants: a critical evaluation. Free Radical Res 20:119-133
86. Selvakumar E, Prahalathan C, Sudharsan PT, Varalakshmi P (2006a) Protective effect of lipoic acid on micronuclei induction by cyclophosphamide. Arch Toxicol 80:115-119
87. Selvakumar E, Prahalathan C, Varalakshmi P, Kumarasamy P, Saravanan R (2006b) Modification of cyclophosphamide-induced clastogenesis and apoptosis in rats by α-lipoic acid. Mutat Res 606:85-91
88. Sen CK, Roy S, Packer L (1999) α-Lipoic acid: cell regulatory function and potential therapeutic implications. In: Packer LM, Hiramatsu T, Yoshikawa T (eds) Antioxidant food supplements in human health. Academic Press, San Diego, pp 111-120
89. Sewierenga SHH, Heddle JA, Sigal EA, Gilman JP, Brillinger RL, Douglas GR, Nestmann ER (1991) Recommended protocols based on a survey of current practice in genotoxicity testing laboratories. IV. Chromosome aberrations and sister chromatid exchanges in Chineese Hamster Ovary V79. Chineese Hamster lung and human lymphocyte cultures. Mutat Res 246:301-322
90. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM (2009) Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. BBA-Mol Cell Res 1790:1149-1160
91. Siddique YH, Beg T, Afzal M (2008) Antigenotoxic effect of apigenin against anti-cancerous drugs. Toxicol In Vitro 22:625-631
92. Speit G, Houpter S (1985) On the mechanism of differential Giemsa staining of bromodeoxyuridine substitute chromosomes. II. Differences between the demonstration of sister chromatid differentiation and replication patterns. Hum Genet 70:126-129
93. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM (2004a) Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci USA 101:3381-3386
94. Suh JH, Wang H, Liu H, Liu RM, Hagen TM (2004b) (R)-α-lipoic acid reverses the age-related loss in GSH redox status in postmitotic tissues: evidence for increased cysteine requirement for GSH synthesis. Arch Biochem Biophys 423:126-135
95. Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768-780
96. Szybalski W, Iyer VN (1964) Crosslinking of DNA by enzymatic or activated mitomycin and porfiromycins, bifonctionally alkylating antibiotics. Feder Proc 23:946-957
97. Teichert J, Kern J, Tritschler HJ, Ulrich H, Preiss R (1998) Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 36:625-628
98. Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P, Preiss R (2005) Pharmacokinetics of α-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J Clin Pharmacol 45:313-328
99. Tian YF, Hsieh CH, Hsieh YJ, Chen YT, Peng YJ, Hsieh PS (2012) a-Lipoic acid preventsmild portal endotoxaemiainduced hepatic inflammation and b cell dysfunction. Eur J Clin Invest 42:637-648
100. Tomasz M (1995) Mitomycin C: small, fast and deadly (but very selective). Chem Biol 2:575-579
101. Turkez H, Aydin E, Aslan A (2012) Xanthoria elegans (Link) (lichen) extract counteracts DNA damage and oxidative stress of mitomycin C in human lymphocytes. Cytotechnology. doi: 10.1007/s10616-012-9447-0
102. Ünal F, YüzbaŚIoǧlu D, YIlmaz S, AkIncI N, Aksoy H (2011) Genotoxic effects of chlorophenoxy herbicide diclofop-methyl in mice in vivo and in human lymphocytes in vitro. Drug Chem Toxicol 34:390-395
103. Weakley SM, Jiang J, Kougias P, Lin PH, Yao Q, Brunicardi FC, Gibbs RA, Chen C (2010) Role of somatic mutations in vascular disease formation. Expert Rev Mol Diagn 10:173-185
104. Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209-240
105. 2-generation. Apoptosis 10:359-368
106. Xiao Y, Cui J, Shi Y, Le G (2012) Alpha-lipoic acid protects against hydrogen peroxide-induced oxidative stress in MC3T3-E1 osteoblast-like cells. J Func Foods 4:642-649
107. Zhang WJ, Frei B (2001) Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappa B activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15:2423-2432